Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113045489B details a novel Pd-catalyzed aminocarbonylation route for 3-arylquinolin-2(1H)ones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel CuCl-catalyzed route offers cost reduction and scalable production for high-purity pharmaceutical intermediates without anhydrous conditions.
Novel Pd-catalyzed one-pot method for trifluoromethyl chromone quinoline. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel axial chiral bisindole catalysts for asymmetric synthesis. Superior stereoselectivity and mild conditions for pharmaceutical intermediates manufacturing.
Novel palladium-catalyzed carbonylation patent CN115286628B enables efficient synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN102964271B details a novel one-step Pd-catalyzed synthesis of 2-cyano-4'-methylbiphenyl, offering significant cost reduction and scalability for sartan drug manufacturers.
Novel metal-free synthesis of trifluoromethyl 1,2,4-triazines via [3+3] cycloaddition. Offers cost reduction in API manufacturing and scalable production capabilities.
Patent CN116253692A enables efficient, metal-free synthesis of trifluoromethyl triazines under ambient conditions, offering significant cost savings and supply chain reliability for pharmaceutical intermediates.
Patent CN107522606B enables efficient synthesis of 1,4-ketoaldehyde with mild conditions and copper catalysis, offering supply chain reliability and cost reduction for pharmaceutical intermediates.
This patent reveals a novel Pd-catalyzed route for 2-trifluoromethyl quinazolinone, offering high yields and broad substrate scope, enabling cost reduction in pharmaceutical intermediate manufacturing.
This patent introduces a novel dual-chiral ligand enabling high enantioselectivity in asymmetric catalysis, offering significant cost reduction and supply chain reliability for API intermediates manufacturing.
Patent CN116621792B enables efficient, water-based synthesis of N-butyl-benzisothiazolinone oxide with high yield, offering sustainable cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN115611739B enables high-purity benpropenoic acid intermediate synthesis with simplified steps, safer reagents, and scalable production for global pharmaceutical supply chains.
Patent CN115260080B enables efficient one-step synthesis of indole-3-carboxamide with high substrate tolerance, offering scalable production and cost reduction for pharmaceutical intermediates.
Novel four-component one-step synthesis enables high-yield, scalable production of structurally diverse calixarene derivatives with superior recognition properties for industrial applications.
This patent reveals a novel, iron-catalyzed route for 2-trifluoromethyl quinazolinone, offering scalable synthesis with high purity and reduced manufacturing costs for pharmaceutical applications.
This patent introduces a novel palladium-catalyzed carbonylation route for pyrone derivatives using nitroarenes and molybdenum carbonyl, enabling scalable, cost-efficient synthesis with broad substrate tolerance for pharmaceutical intermediates.
Patent CN118271227A enables scalable, mild synthesis of 4-formylpyrrole derivatives via silver catalysis, offering high yield and simplified purification for pharmaceutical supply chains.
This patent reveals a novel carbonylation method for thioester synthesis, eliminating malodorous thiols and enabling scalable, cost-effective production for pharmaceutical intermediates.
Patent CN120398774A enables high-yield, mild-condition synthesis of C-3 alkylated quinoxalinones, offering scalable routes with simplified purification for pharmaceutical supply chains.